Outlook
Outlook until 2024/25
Elekta’s strategy provides the framework for our pursuit of profitable growth in a sustainable way and is quantified in the financial outlook.
Net sales
Elekta had a net sales growth rate of 5 percent in 2023/24 based on constant exchange rates. In SEK, net sales growth was 7 percent.
EBIT margin
In 2023/24, Elekta’s adjusted EBIT margin1) increased to 11.8 percent. This was driven by higher sales and cost control. During 2023/24, activities of the Cost-reduction Initiative from 2022/23 have continued, although at a significantly lower level.
1) Adjusted EBIT = Operating income (EBIT) excluding items affecting comparability
Dividend policy
Elekta’s goal is to provide shareholders with a favorable return and value growth. The policy is to distribute at least 50 percent of profit for the year in the form of dividend, repurchase of shares or comparable measures. A dividend decision is based on Elekta’s financial position, earnings trend, growth potential and investment requirements.
Dividend
For 2023/24 the dividend proposal is 2.40 SEK/share, which corresponds to 70% of the net income.
Strategic milestones - outcome 2023/24
Availability of care
At end of year 2023/24 more than 260 million people in underserved markets had gotten access to treatment via Elekta’s installed base of linacs (baseline 2019/20).
Elevation of care
Online adaptive treatments are driven by Elekta Unity as the MR-Linac can adapt the treatment plan in real time to changing tumor and surrounding tissue anatomy.
100 percent of Unity treatments are adapted, of which around 60 percent are adapt to shape and around 40 percent adapt to position. More than 50 percent of Unity treatments are stereotactic body radiotherapy
(hypofractionation).
Participation of care
Through the Kaiku app, patients can interact with their clinicians, who get access to the patients and their symptom feedback and will react to the patients
well-being, if necessary. A positive experience for the patient and efficient problem solving for the clinicians
